Maxim Group is acting as the exclusive placement agent for this offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNRX:
- Quoin Pharmaceuticals Annual Meeting Approves Key Amendments
- Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges
- Quoin Pharmaceuticals reports Q3 EPS ($1.63), consensus (49c)
- Quoin Pharmaceuticals sees cash runway into late 2025
- Quoin Pharmaceuticals continues to evaluate M&A opportunities